Health care companies by P/B ratio
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
MiniMed Group has the lowest figure of the 128 health care companies ranked by P/B ratio, at 1.3, followed by CVS Health (1.3) and Bio-Rad Laboratories (1.3). Figures as of 19 Nov 2026, 15:20 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 128
- Lowest
- MiniMed Group1.3
- Median
- 5.5
- Combined market value
- ZAR 157.44T
- Countries
- 14
- Not ranked
- 42no P/B ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/B ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | MiniMed GroupMMED · Health Care | 1.3 | ZAR 80.7B | ZAR 286.74 | 3.35% down | 8% down | ||
| 2 | CVS HealthCVS · Health Care | 1.3 | ZAR 1.8T | ZAR 1,403.48 | 1.20% down | 7% up | ||
| 3 | Bio-Rad LaboratoriesBIO · Health Care | 1.3 | ZAR 177.8B | ZAR 6,612.77 | 2.30% up | 22% up | ||
| 4 | Universal Health ServicesUHS · Health Care | 1.4 | ZAR 179.5B | ZAR 3,113.38 | 4.18% down | 17% down | ||
| 5 | Cooper CompaniesCOO · Health Care | 1.4 | ZAR 199.8B | ZAR 1,050.55 | 0.97% down | 15% down | ||
| 6 | CenteneCNC · Health Care | 1.5 | ZAR 563.1B | ZAR 1,137.34 | 3.44% down | 94% up | ||
| 7 | Zimmer Biomet HoldingsZBH · Health Care | 1.5 | ZAR 342.5B | ZAR 1,809.66 | 0.30% up | 16% up | ||
| 8 | Cigna GroupCI · Health Care | 1.7 | ZAR 1.27T | ZAR 4,807.13 | 3.54% down | 6% up | ||
| 9 | ViatrisVTRS · Health Care | 1.7 | ZAR 401.1B | ZAR 349.86 | 1.21% down | 99% up | ||
| 10 | PfizerPFE · Health Care | 1.8 | ZAR 2.75T | ZAR 482.41 | 1.55% down | 15% up | ||
| 11 | AvantorAVTR · Health Care | 1.8 | ZAR 182.3B | ZAR 269.10 | 0.26% up | 40% up | ||
| 12 | Elevance HealthELV · Health Care | 1.9 | ZAR 1.46T | ZAR 6,777.96 | 3.17% down | 28% up | ||
| 13 | TeleflexTFX · Health Care | 1.9 | ZAR 115.1B | ZAR 2,901.42 | 0.18% up | 58% up | ||
| 14 | Globus MedicalGMED · Health Care | 1.9 | ZAR 161.5B | ZAR 1,219.42 | 0.99% down | 14% down | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | 1.9 | ZAR 213B | ZAR 1,099.80 | 2.52% up | 17% up | ||
| 16 | BiogenBIIB · Health Care | 2.0 | ZAR 644.8B | ZAR 4,362.35 | 0.64% down | 49% up | ||
| 17 | GRAILGRAL · Health Care | 2.0 | ZAR 85.7B | ZAR 1,906.23 | 6.91% up | 19% up | ||
| 18 | Elanco Animal HealthELAN · Health Care | 2.0 | ZAR 235B | ZAR 470.10 | 0.82% up | 26% up | ||
| 19 | Baxter InternationalBAX · Health Care | 2.0 | ZAR 231.9B | ZAR 448.18 | 1.89% down | 50% up | ||
| 20 | Becton, DickinsonBDX · Health Care | 2.4 | ZAR 1.02T | ZAR 3,733.43 | 1.06% down | 45% up | ||
| 21 | RevvityRVTY · Health Care | 2.4 | ZAR 303.2B | ZAR 2,716.15 | 2.04% up | 62% up | ||
| 22 | Legend BiotechLEGN · Health Care | 2.4 | ZAR 53.9B | ZAR 278.01 | 2.03% down | 41% down | ||
| 23 | HumanaHUM · Health Care | 2.4 | ZAR 801.5B | ZAR 6,673.01 | 0.95% down | 73% up | ||
| 24 | Boston ScientificBSX · Health Care | 2.5 | ZAR 1.11T | ZAR 762.42 | 0.05% up | 55% down | ||
| 25 | Molina HealthcareMOH · Health Care | 2.5 | ZAR 182.9B | ZAR 3,504.50 | 2.84% down | 54% up | ||
| 26 | Align TechnologyALGN · Health Care | 2.7 | ZAR 199.7B | ZAR 2,832.62 | 1.07% down | 23% up | ||
| 27 | Edgewise TherapeuticsEWTX · Health Care | 2.8 | ZAR 78.7B | ZAR 718.59 | 0.53% down | 86% up | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 2.8 | ZAR 1.7T | ZAR 16,391.00 | 0.73% down | 28% up | ||
| 29 | MedlineMDLN · Health Care | 2.8 | ZAR 872.4B | ZAR 662.88 | 3.06% down | 4% down | ||
| 30 | Merit Medical SystemsMMSI · Health Care | 2.9 | ZAR 89B | ZAR 1,485.20 | 1.02% down | 1% up | ||
| 31 | Henry ScheinHSIC · Health Care | 2.9 | ZAR 162.1B | ZAR 1,466.34 | 2.01% down | 20% up | ||
| 32 | WatersWAT · Health Care | 3.0 | ZAR 1.6T | ZAR 8,148.44 | 0.11% up | 23% up | ||
| 33 | DanaherDHR · Health Care | 3.0 | ZAR 2.83T | ZAR 4,025.85 | 0.86% up | 3% up | ||
| 34 | SolventumSOLV · Health Care | 3.1 | ZAR 256B | ZAR 1,506.51 | 0.24% down | 9% up | ||
| 35 | UnitedHealth GroupUNH · Health Care | 3.1 | ZAR 5.31T | ZAR 5,921.59 | 3.09% down | 12% up | ||
| 36 | GE HealthCare TechnologiesGEHC · Health Care | 3.2 | ZAR 654.3B | ZAR 1,447.04 | 0.95% down | 12% up | ||
| 37 | Labcorp HoldingsLH · Health Care | 3.4 | ZAR 523.9B | ZAR 6,451.50 | 0.36% down | 42% up | ||
| 38 | LifeStance Health GroupLFST · Health Care | 3.5 | ZAR 90B | ZAR 236.62 | 1.60% down | 123% up | ||
| 39 | Abbott LaboratoriesABT · Health Care | 3.6 | ZAR 3.17T | ZAR 1,832.18 | 0.42% up | 16% down | ||
| 40 | Option Care HealthOPCH · Health Care | 3.6 | ZAR 82.8B | ZAR 552.61 | 0.20% down | 12% up | ||
| 41 | VaxcytePCVX · Health Care | 3.6 | ZAR 166.3B | ZAR 1,050.55 | 2.80% up | 23% up | ||
| 42 | Quest DiagnosticsDGX · Health Care | 3.7 | ZAR 498.2B | ZAR 4,528.42 | 0.14% down | 38% up | ||
| 43 | Oscar HealthOSCR · Health Care | 3.7 | ZAR 145.5B | ZAR 468.17 | 2.76% down | 112% up | ||
| 44 | United TherapeuticsUTHR · Health Care | 3.8 | ZAR 422.5B | ZAR 9,920.55 | 1.60% down | 22% up | ||
| 45 | Tenet HealthcareTHC · Health Care | 3.9 | ZAR 366.4B | ZAR 4,604.12 | 2.83% down | 45% up | ||
| 46 | Dianthus TherapeuticsDNTH · Health Care | 3.9 | ZAR 84.7B | ZAR 1,504.58 | 2.60% up | 108% up | ||
| 47 | HealthEquityHQY · Health Care | 4.1 | ZAR 141.2B | ZAR 1,707.15 | 0.46% up | 3% down | ||
| 48 | Ensign GroupENSG · Health Care | 4.1 | ZAR 183.6B | ZAR 3,146.77 | 1.52% down | 2% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | 4.1 | ZAR 69.3B | ZAR 505.89 | 0.52% down | 168% up | ||
| 50 | Neurocrine BiosciencesNBIX · Health Care | 4.2 | ZAR 283.5B | ZAR 2,801.19 | 1.50% down | 17% up | ||
| 51 | IncyteINCY · Health Care | 4.2 | ZAR 417.4B | ZAR 2,047.85 | 0.45% down | 16% up | ||
| 52 | BrukerBRKR · Health Care | 4.4 | ZAR 174.5B | ZAR 1,142.85 | 3.45% up | 44% up | ||
| 53 | Royalty PharmaRPRX · Health Care | 4.5 | ZAR 686.7B | ZAR 1,194.27 | 0.41% down | 79% up | ||
| 54 | Thermo Fisher ScientificTMO · Health Care | 4.7 | ZAR 4.53T | ZAR 12,227.02 | 1.07% up | 21% up | ||
| 55 | MSA SafetyMSA · Health Care | 4.8 | ZAR 119.1B | ZAR 3,090.55 | 0.26% down | 16% up | ||
| 56 | Encompass HealthEHC · Health Care | 4.8 | ZAR 224.1B | ZAR 2,284.29 | 3.05% down | 20% up | ||
| 57 | RepligenRGEN · Health Care | 4.8 | ZAR 197.6B | ZAR 3,091.24 | 2.52% up | 12% up | ||
| 58 | Lantheus HoldingsLNTH · Health Care | 4.9 | ZAR 116.6B | ZAR 1,782.24 | 0.06% up | 90% up | ||
| 59 | RadNetRDNT · Health Care | 5.0 | ZAR 97.6B | ZAR 1,238.98 | 1.21% down | 9% down | ||
| 60 | Charles River Laboratories InternationalCRL · Health Care | 5.0 | ZAR 282.7B | ZAR 5,899.42 | 1.37% up | 106% up | ||
| 61 | Bristol-Myers SquibbBMY · Health Care | 5.1 | ZAR 2.09T | ZAR 1,024.10 | 1.54% down | 30% up | ||
| 62 | StrykerSYK · Health Care | 5.1 | ZAR 2.1T | ZAR 5,512.09 | 0.79% down | 12% down | ||
| 63 | Bio-TechneTECH · Health Care | 5.3 | ZAR 199.5B | ZAR 1,270.06 | 0.03% down | 24% up | ||
| 64 | ErascaERAS · Health Care | 5.4 | ZAR 87B | ZAR 247.80 | 3.12% up | 395% up | ||
| 65 | Alnylam PharmaceuticalsALNY · Health Care | 5.5 | ZAR 348.4B | ZAR 2,600.89 | 0.31% down | 66% down | ||
| 66 | Edwards LifesciencesEW · Health Care | 5.6 | ZAR 1.06T | ZAR 1,835.33 | 0.12% down | 25% up | ||
| 67 | Oruka TherapeuticsORKA · Health Care | 5.6 | ZAR 118B | ZAR 1,740.51 | 4.10% up | 255% up | ||
| 68 | ResMedRMD · Health Care | 5.6 | ZAR 584.7B | ZAR 4,157.25 | 1.87% down | 1% down | ||
| 69 | PACS GroupPACS · Health Care | 5.7 | ZAR 120.3B | ZAR 758.23 | 6.22% down | 77% up | ||
| 70 | InsuletPODD · Health Care | 6.1 | ZAR 168.8B | ZAR 2,433.42 | 0.45% down | 55% down | ||
| 71 | Ligand PharmaceuticalsLGND · Health Care | 6.1 | ZAR 103.3B | ZAR 5,162.67 | 1.03% down | 50% up | ||
| 72 | HaemoneticsHAE · Health Care | 6.2 | ZAR 96.8B | ZAR 2,126.69 | 0.87% down | 64% up | ||
| 73 | BrightSpring Health ServicesBTSG · Health Care | 6.3 | ZAR 228.9B | ZAR 1,150.18 | 3.62% down | 109% up | ||
| 74 | Kymera TherapeuticsKYMR · Health Care | 6.4 | ZAR 179.9B | ZAR 2,107.83 | 0.35% down | 87% up | ||
| 75 | IQVIA HoldingsIQV · Health Care | 6.4 | ZAR 743.1B | ZAR 4,509.21 | 0.15% up | 19% up | ||
| 76 | Vertex PharmaceuticalsVRTX · Health Care | 6.5 | ZAR 2.37T | ZAR 9,342.97 | 0.27% down | 27% up | ||
| 77 | Krystal BiotechKRYS · Health Care | 6.5 | ZAR 163.3B | ZAR 5,510.00 | 0.06% up | 54% up | ||
| 78 | VeradermicsMANE · Health Care | 6.7 | ZAR 93B | ZAR 2,205.19 | 1.14% up | 231% up | ||
| 79 | Agilent TechnologiesA · Health Care | 6.9 | ZAR 885.8B | ZAR 3,141.62 | 1.45% up | 22% up | ||
| 80 | Praxis Precision MedicinesPRAX · Health Care | 7.1 | ZAR 155.6B | ZAR 5,568.15 | 4.48% up | 86% up | ||
| 81 | Merck & CoMRK · Health Care | 7.4 | ZAR 5.82T | ZAR 2,360.13 | 1.91% down | 45% up | ||
| 82 | CG OncologyCGON · Health Care | 7.5 | ZAR 129.5B | ZAR 1,450.01 | 3.79% up | 97% up | ||
| 83 | BillionToOneBLLN · Health Care | 7.6 | ZAR 75.7B | ZAR 1,585.26 | 0.83% down | 4% down | ||
| 84 | Protagonist TherapeuticsPTGX · Health Care | 7.7 | ZAR 146.1B | ZAR 2,238.72 | 0.82% up | 51% up | ||
| 85 | Johnson & JohnsonJNJ · Health Care | 7.9 | ZAR 11.24T | ZAR 4,668.65 | 1.96% down | 34% up | ||
| 86 | Belite BioBLTE · Health Care | 8.0 | ZAR 110.5B | ZAR 2,719.81 | 0.31% down | 43% up | ||
| 87 | PenumbraPEN · Health Care | 8.0 | ZAR 220.7B | ZAR 5,599.93 | 0.02% up | 15% up | ||
| 88 | ChemedCHE · Health Care | 8.2 | ZAR 123.5B | ZAR 9,528.95 | 0.19% down | 27% up | ||
| 89 | Corcept TherapeuticsCORT · Health Care | 8.7 | ZAR 127.1B | ZAR 1,161.27 | 1.90% down | 10% down | ||
| 90 | Caris Life SciencesCAI · Health Care | 8.9 | ZAR 99.3B | ZAR 346.11 | 1.64% up | 19% down | ||
| 91 | ExelixisEXEL · Health Care | 8.9 | ZAR 284.7B | ZAR 1,166.86 | 2.15% down | 63% up | ||
| 92 | Intuitive SurgicalISRG · Health Care | 9.1 | ZAR 2.54T | ZAR 7,314.77 | 0.49% down | 24% down | ||
| 93 | Twist BioscienceTWST · Health Care | 9.3 | ZAR 144.7B | ZAR 2,121.72 | 4.43% up | 346% up | ||
| 94 | 10x GenomicsTXG · Health Care | 9.4 | ZAR 138.2B | ZAR 1,050.90 | 5.45% up | 247% up | ||
| 95 | West Pharmaceutical ServicesWST · Health Care | 9.5 | ZAR 491.2B | ZAR 7,050.73 | 0.06% down | 57% up | ||
| 96 | Spyre TherapeuticsSYRE · Health Care | 10.0 | ZAR 167.3B | ZAR 1,761.64 | 0.57% down | 332% up | ||
| 97 | ZoetisZTS · Health Care | 10.2 | ZAR 586.8B | ZAR 1,444.16 | 3.35% down | 26% down | ||
| 98 | Concentra Group Holdings ParentCON · Health Care | 10.3 | ZAR 91B | ZAR 723.48 | 1.16% down | 116% up | ||
| 99 | IlluminaILMN · Health Care | 10.4 | ZAR 567.5B | ZAR 3,753.12 | 2.34% up | 76% up | ||
| 100 | ImmunovantIMVT · Health Care | 10.5 | ZAR 120.6B | ZAR 582.56 | 0.57% up | 46% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4627 ZAR). 42 companies have no P/B ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/B ratio?
MiniMed Group (1.3), CVS Health (1.3) and Bio-Rad Laboratories (1.3) have the lowest P/B ratio of the 128 health care companies ranked here as of 19 Nov 2026, 15:20 UTC.
How many health care companies are in this ranking?
128 are ranked by P/B ratio. 42 more have no P/B ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 128 health care companies ranked by P/B ratio have a combined market value of ZAR 157.44T as of 19 Nov 2026, 15:20 UTC.
What does ranking by P/B ratio measure?
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/B ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pb-ratio
Underlying data: Yahoo Finance; SEC EDGAR.